Gabriella Cohn Cedermark
Papers
1
Total Citations
3
H-Index
1
About
Gabriella Cohn Cedermark is a leading oncologist and researcher whose work centers on testicular cancer, particularly within the Scandinavian SWENOTECA (Swedish Norwegian Testicular Cancer Group) collaboration. Her major contribution lies in pioneering the use of primary retroperitoneal lymph node dissection (RPLND) as a treatment for seminoma stage IIA-IIB, challenging the traditional reliance on chemotherapy or radiotherapy. This work, detailed in her most-cited paper from 2023, offers a promising avenue to reduce long-term toxicity in young patients. While her citation count is still growing, reflecting the recent publication of this landmark study, its immediate impact is evident in the international urologic oncology community. Cedermark’s research is reshaping clinical guidelines by providing robust evidence for surgical management in early-stage seminoma, directly improving patient quality of life. Her dedication to collaborative, multi-center trials underscores a career committed to translating rigorous clinical data into practice-changing protocols for testicular cancer care.
Research Focus
Key Achievements
Top Papers
- 1